Quad Asset Management logo

Quad Asset Management

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Quad Asset Management is an Investment firm.

Investor Profile

Quad Asset Management has made 7 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (43%)
  • Series C (29%)
  • Series B (14%)
  • Series Unknown (14%)

Country Focus

  • South Korea (86%)
  • United States (14%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Medical
  • Software
  • Robotics
  • Machine Learning
  • Neuroscience
  • Biopharma
  • Online Portals
  • Sports
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Quad Asset Management frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Korea Technology Finance Corporation
Asia, Pusan-jikhalsi, South Korea, Busan
Co-Investments: 1
TONY Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Korea Development Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Union Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Solidus Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Shinyoung Securities
Asia, Seoul-t'ukpyolsi, South Korea, Yongdungpo
Co-Investments: 1
Mint Venture Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Atinum Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

Which angels does Quad Asset Management often collaborate with?

SK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Quad Asset Management?

Ubix Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

BiotechnologyMedical
Series CDec 23, 2024
Amount Raised: $17,716,685
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
Cubixel

Seoul, Seoul-t'ukpyolsi, South Korea

Cubixel develops and commercializes optical inspection equipment for the medical and bio industry.

BiotechnologyMedical
Series UnknownSep 6, 2024
Amount Raised: $12,698,223
NEUROPHET

Gangneung, Kangwon-do, South Korea

NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.

Artificial Intelligence (AI)Machine LearningMedicalNeuroscienceSoftware
Series CNov 7, 2023
Amount Raised: $15,325,964
Creatz

Suwon, Ch'ungch'ong-namdo, South Korea

Creatz is a sports consulting online platform based on artificially generated data.

Artificial Intelligence (AI)Online PortalsSports
Series ADec 8, 2021
Amount Raised: $21,319,234
AKA

Santa Monica, California, United States

AKA is the invincible Generative AI company: to create revolutionary and life-saving AI product

Artificial Intelligence (AI)RoboticsSoftware
Series BJan 8, 2021
Amount Raised: $17,383,190
Rznomics

Gwangju, Kwangju-jikhalsi, South Korea

Rznomics is a biotechnology company.

BiopharmaBiotechnology
Series AOct 30, 2019
Amount Raised: $10,303,083